Close

Dr Ajay K Agrawal Director, Ecron Acunova GmbH Dr Ajay K Agrawal has extensive experience in the biotech & pharma industry worldwide. Dr Agrawal was a founder of polyMASC Pharmaceuticals plc, London, the first UK biotech company from a university that was directly listed on AIM, raising approximately $40 million in 1995, and subsequently merged with a NASDAQ-listed company, Valentis Inc, USA in 1999 to become one of the biggest companies in the delivery of biologics at that time. He has been the Managing Director of the Worldwide organization of collaborations in the pharmaceutical industry, London, and Director of business development of Lipoxen plc, AIM-listed company, in London. Dr Agrawal has been an entrepreneur and advisor to the number of companies worldwide, and is currently a non-executive director, chairman of the remuneration and vice chairman of audit committees of ImmuPharma plc, AIM-listed company in London with operations in France and Switzerland, in the Board of Directors of Clinovo Ltd UK, Director of business development Almac Sciences UK, and a special advisor on healthcare for commonwealth British council, London. Dr Agrawal currently sits on the editorial advisory board of four international pharmaceutical journals from the USA.